This control plane turns synthetic deviation and CAPA exports into one review surface: root-cause packet continuity, accountable ownership, effectiveness checks, recurrence pressure, retraining evidence, and final batch disposition completeness before downstream handoff.
Biotech teams need one board where root-cause evidence, CAPA ownership, effectiveness checks, recurrence pressure, retraining proof, and final disposition stay readable together.
This fits the Kinetic Gain pattern: routing, evidence, approvals, and operator-safe remediation posture for quality-critical work.
The free surface proves the operator model; the commercial path is an embedded deviation and CAPA module for regulated biotech quality workflows.
Root-cause packet status, CAPA owner continuity, effectiveness posture, recurrence pressure, retraining proof, and final disposition stay in one quality lane.
The ledger makes repeated missing owners, stale training evidence, and unresolved recurrence patterns visible before they create another batch-review loop.
Blocking gaps show whether investigation intake, CAPA assignment, effectiveness checks, training proof, or disposition signoff should get the next automation pass.
| Signal | Owner | Required proof | Decision supported |
|---|---|---|---|
| Root-cause packet | Manufacturing QA | Deviation record, investigation summary, impacted lot, disposition note | Quarantine, rework, or advance batch review |
| CAPA effectiveness | Process Excellence | Corrective action, owner, verification window, recurrence check | Close CAPA, extend monitoring, or escalate quality risk |
| Training and disposition | Quality Systems | Retraining record, signer, SOP version, final release posture | Release, hold, or require packet repair |